---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-151729"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:13:14.771129+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aligos receives Nasdaq notice for Audit Committee noncompliance; cure period to Nov 2024

## Summary
- Jack Nielsen resigned from Board and Audit Committee on May 21, 2024, causing noncompliance with Rule 5605.
- Nasdaq granted cure period until Nov 18, 2024, as next annual meeting is June 27, 2024.
- Company plans to appoint a third independent director to the Audit Committee before the cure deadline.

## SEC filing metadata
- accession: 0001193125-24-151729
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312524151729/0001193125-24-151729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524151729/d808483d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-151729
- JSON: https://secwatch.observer/filing/0001193125-24-151729.json
- Plain text: https://secwatch.observer/filing/0001193125-24-151729.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.